Israel Englander Merck & Co., Inc. Put Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $53.8 Million - $57.8 Million	-434,800 Reduced 41.22%	620,100 $76.8 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $33.8 Million - $39.4 Million	298,800 Added 39.52%	1,054,900 $139 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $8.97 Million - $9.76 Million	-89,500 Reduced 10.58%	756,100 $82.4 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $53 Million - $57.8 Million	488,200 Added 136.6%	845,600 $97.6 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $105 Million - $117 Million	-1,017,700 Reduced 74.01%	357,400 $38 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $29.5 Million - $37.8 Million	-337,000 Reduced 19.68%	1,375,100 $153 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $7.97 Million - $8.95 Million	-94,300 Reduced 5.22%	1,712,100 $147 Million

3,802

1.92B

13.4M

10.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $255B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.